Professor Gilles Karcher (PhD, MD) is a SUPELEC engineer and physician specialist in nuclear medicine. He is a professor of biophysics at the University of Lorraine and professor of nuclear medicine at the University Hospital of Nancy. Gilles Karcher is currently Head of the Department of Nuclear Medicine and the Imaging Division of the University Hospital of Nancy. He is responsible for the creation of Nancylotep with the aim of making the latter a tool for accelerating the transfer of research to clinical applications in nuclear medicine, and in particular for the implementation of new radiopharmaceuticals.
Pr Gilles KARCHER
Chairman and Founder Nancyclotep
Marjorie Fougère (PhD), engineer and doctor in life sciences, joined Nancyclotep as General Manager in June 2018. Previously, Marjorie assisted Greater East companies in their innovation projects within the Regional Council. Marjorie also worked as a junior scientist in a biotechnology company.
General Manager and Head of the e-learning platform
Pierre-Yves Marie (PhD, MD), specialist in nuclear medicine, MRI and cardiovascular diseases, is a University professor and hospital practitioner (PU-PH) in nuclear medicine, and current Vice-President of Research and Head of the Research Support Facilities Pole at the University Hospital of Nancy. Recognized for his experience and research work, Pierre-Yves Marie has been the scientific director of Nancyclotep since its creation.
Pr Pierre Yves MARIE
Chief Scientific Officer
Fatiha Maskali (PhD), biologist and expert in radioisotopic imaging in animals, member of the Lorraine Ethics Committee, joined Nancyclotep at its creation and spearheaded the creation of the Preclinical Imaging Platform (PRIPA) that she currently heads.
Head of the preclinical platform
Charlotte Collet (PhD), a specialist in organic chemistry, joined Nancyclotep in 2013. She established the radiochemistry laboratory which she currently heads. She was appointed Research Engineer at the University of Lorraine in 2016 in the IADI laboratory.
Head of the radiochemistry laboratory
Véronique Roch (MSc, Bioengineering Medicines and NanoHealth) is a hospital engineer at the University Hospital of Nancy. She has been present at Nancyclotep since its creation. Previously a clinical studies technician, she has been a project manager since 2015 and actively participates with nuclear physicians in the drafting of clinical research projects.
Head of Clinical Research Projects
Julien Tea (PharmD, MSc) is a Pharmacist and Chemical Industries Engineer. He joined Nancyclotep in April 2017. Julien also worked in the Technical Services / Manufacturing Sciences Department at Lilly France (2015) and as a production pharmacist at Cyclopharma (2016 - 2017).
Head of Pharmaceutical Operations and General Manager of Posifit
Pierre Olivier is a University professor and hospital practitioner (PU-PH) in nuclear medicine at the University Hospital of Nancy. He works in close collaboration with Nancylotep for clinical studies.
Pr Pierre OLIVIER
MD, University Hospital of Nancy, PU-PH, CHRU Nancy
Antoine Verger is senior University lecturer and hospital practitioner (MCU-PH) in nuclear medicine at the University Hospital of Nancy. An international specialist in neurology, he is the scientific leader within Nancyclotep for clinical studies and image processing.
Dr Antoine VERGER
MD, University Hospital of Nancy, MCU-PH, CHRU Nancy
Nicolas Veran (Pharm D) is a radiopharmacist at the University Hospital of Nancy since 2013. Highly involved in research, he works in close collaboration with the Nancyclotep teams in R&D.
Radiopharmacist, University Hospital of Nancy, PharmD, CHRU Nancy
Laetitia (PhD), an expert in molecular imaging systems, is a leader in applied research and image processing in the Nuclear Medicine department. Present at Nancylotep since its creation, she brings her expertise and contributes to the implementation of Nancyclotep's state-of-the-art high-quality imaging fleet (digital PET, CZT camera…).
Medical physicist, PhD, certified in radiation safety, University Hospital of Nancy
Philippe Montreuil has a thorough understanding of the medical world in general and of Nuclear Medicine in particular in which he has been involved for the better part of 20 years. He was CEO of Thélème before creating his consulting company. Thanks to this rich experience, he is the interlocutor between the experts and the Doxaca development team.